...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International Journal of Environmental Research and Public Health >Implant Placement in Patients under Treatment with Rivaroxaban: A Retrospective Clinical Study
【24h】

Implant Placement in Patients under Treatment with Rivaroxaban: A Retrospective Clinical Study

机译：利维拉沙巴治疗患者的植入植入物：回顾性临床研究

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The management of patients under treatment with Direct Oral Anticoagulants (DOACs) has led clinicians to deal with two clinical issues, such as the hemorrhagic risk in case of non-interruption or the risk of thromboembolism in case of suspension of the treatment. The primary aim of this retrospective study was to evaluate the incidence of perioperative bleeding events and healing complications in patients who were under treatment with Rivaroxaban and who received dental implants and immediate prosthetic restoration. Patients treated with Rivaroxaban (Xarelto 20 mg daily) and who needed implant rehabilitation were selected. Four to six implants were placed in mandibular healed sites or fresh extraction sockets. All patients, in agreement with their physicians, interrupted the medication for 24 h and received implants and immediate restorations. Twelve patients and 57 implants were analyzed in the study. No major postoperative bleeding events were reported. Three patients (25%) presented slight immediate postoperative bleeding controlled with compression only. The implant and prosthetic survival rate were both 100% after 1 year. Within the limitations of this study, multiple implant placement with an immediate loading can be performed without any significant complication with a 24 h discontinuation of Rivaroxaban, in conjunction with the patient’s physician.
机译：用直接口服抗凝血剂（Doacs）治疗患者的管理已经LED临床医生处理两种临床问题，例如在悬浮治疗的情况下在非中断或血栓栓塞风险的情况下出血风险。这种回顾性研究的主要目的是评估围手术期出血事件和患者患者治疗的愈合并发症，以及接受牙科植入物和立即假期修复的患者。选择患有Rivaroxaban（每天Xarelto 20毫克）和需要植入康复的患者。将四到六个植入物置于下颌愈合位点或新鲜提取插座中。所有患者均同意他们的医生，中断了24小时并接受了植入物和立即修复的药物。在研究中分析了12名患者和57例植入物。没有报告任何主要的术后出血。三名患者（25％）略微立即术后出血，仅限压缩。 1年后，植入物和假肢存活率均为100％。在本研究的局限内，可以在与患者的医生结合使用患者的医生，在没有任何显着并发症的情况下进行立即载荷的多种植入物，而没有任何显着的并纳rivaroxaban。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号